{"id":"b197569d-04e1-5cee-b58d-cbdcac4a8435","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-which-nsaids-interact","predicate":"inhibits","statement":"Although ibuprofen, naproxen and celecoxib all had the potential to compete with aspirin for access to the substrate binding channel of cyclooxygenase-1 in vitro, measuring aspirin target engagement directly by mass spectrometry after a single therapeutic dose of each followed by 325 milligrams of aspirin revealed a potent drug-drug interaction between ibuprofen and aspirin and between naproxen and aspirin but not between celecoxib and aspirin.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"af9c9504-8153-5623-9fb2-a785fa4c1b87","mechanism_event_label":"Ibuprofen and naproxen block aspirin in people; celecoxib does not.","subject":{"id":"105efa29-5f66-5005-bea2-8082ae7bd180","slug":"naproxen","display_name":"Naproxen","entity_type_key":"drug"},"object":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"evidence_count":1,"mechanism_event":{"id":"af9c9504-8153-5623-9fb2-a785fa4c1b87","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-which-nsaids-interact-event","event_type":"observed_intervention","label":"Ibuprofen and naproxen block aspirin in people; celecoxib does not.","description":"Although ibuprofen, naproxen and celecoxib all had the potential to compete with aspirin for access to the substrate binding channel of cyclooxygenase-1 in vitro, measuring aspirin target engagement directly by mass spectrometry after a single therapeutic dose of each followed by 325 milligrams of aspirin revealed a potent drug-drug interaction between ibuprofen and aspirin and between naproxen and aspirin but not between celecoxib and aspirin.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"b429f269-1d01-59f4-881a-868de0849d0d","slug":"ibuprofen","display_name":"Ibuprofen","entity_type_key":"drug"},"role":"co_interacting_drug","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"91dc5902-d7b9-5396-bd6b-d386498804dc","slug":"celecoxib","display_name":"Celecoxib","entity_type_key":"drug"},"role":"non_interacting_drug","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"30c0a8c2-f0e7-59cc-8701-3564a677f9b7","slug":"cox1-acetylation-assay","display_name":"Direct mass-spectrometric measurement of cyclooxygenase-1 acetylation in platelets","entity_type_key":"cellular_process"},"role":"measurement_method","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"b677bbcf-dff6-53ad-b217-1274bea2e43f","slug":"cox-active-site-channel","display_name":"The hydrophobic substrate channel of the cyclooxygenase active site","entity_type_key":"protein_state"},"role":"contested_site","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"105efa29-5f66-5005-bea2-8082ae7bd180","slug":"naproxen","display_name":"Naproxen","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/25385584.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b2de8f18887f336c8c735f7ffbd1b72b92e5da43aa6388c229590dea120439f2\", \"start_char\": 0, \"end_char\": 1242, \"text_sha256\": \"b2de8f18887f336c8c735f7ffbd1b72b92e5da43aa6388c229590dea120439f2\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Mass-spectrometric assay of cyclooxygenase-1 acetylation in platelets from volunteers given an NSAID followed by aspirin","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"A single therapeutic dose of ibuprofen, naproxen or celecoxib followed by 325 milligrams of aspirin","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Measures target engagement directly rather than inferring it from platelet function, and separates the drugs. A single dose of each, in volunteers rather than patients.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Ibuprofen and naproxen block aspirin in people; celecoxib does not.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p25385584] Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. (2014). https://pubmed.ncbi.nlm.nih.gov/25385584/ DOI: 10.1073/pnas.1406997111","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Platelets","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"34d69afd-b912-5d7f-84e6-80af71ab889b","evidence_kind":"source_excerpt","locator":"Lines 455-466","start_line":455,"end_line":466,"excerpt":"### asa-which-nsaids-interact\nAlthough ibuprofen, naproxen and celecoxib all had the potential to compete with aspirin for access to the substrate binding channel of cyclooxygenase-1 in vitro, measuring aspirin target engagement directly by mass spectrometry after a single therapeutic dose of each followed by 325 milligrams of aspirin revealed a potent drug-drug interaction between ibuprofen and aspirin and between naproxen and aspirin but not between celecoxib and aspirin.\nCondition category: biomarker_context\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: Ibuprofen and naproxen block aspirin in people; celecoxib does not.\norganism: Human\ntissue_or_cell_type: Platelets\nexperimental_model: Mass-spectrometric assay of cyclooxygenase-1 acetylation in platelets from volunteers given an NSAID followed by aspirin\nlimitations: Measures target engagement directly rather than inferring it from platelet function, and separates the drugs. A single dose of each, in volunteers rather than patients.\nexposure: A single therapeutic dose of ibuprofen, naproxen or celecoxib followed by 325 milligrams of aspirin\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/25385584.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b2de8f18887f336c8c735f7ffbd1b72b92e5da43aa6388c229590dea120439f2\", \"start_char\": 0, \"end_char\": 1242, \"text_sha256\": \"b2de8f18887f336c8c735f7ffbd1b72b92e5da43aa6388c229590dea120439f2\"}\n[asa-p25385584] Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. (2014). https://pubmed.ncbi.nlm.nih.gov/25385584/ DOI: 10.1073/pnas.1406997111","model_system":"Mass-spectrometric assay of cyclooxygenase-1 acetylation in platelets from volunteers given an NSAID followed by aspirin","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p25385584] Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. (2014). https://pubmed.ncbi.nlm.nih.gov/25385584/ DOI: 10.1073/pnas.1406997111","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}